A clinical efficacy of 30% ethenolic extract of Indian propolis and Recaldent™ in management of dentinal hypersensitivity: A comparative randomized clinical trial.

OBJECTIVE: The aim of this study is to evaluate the efficacy of 30% ethenolic extract of Indian propolis compared with Recaldent(™) (casein phosphopeptide-amorphous calcium phosphate) in reduction of dentinals hypersensitivity, a randomized, double-blind, split mouth, controlled clinical trial was conducted among the patients residing in Central Jail. MATERIALS AND METHODS: A sample of 73 teeth from 13 patients having at least three teeth with dentinal hypersensitivity (DH) were randomly allocated into three treatment groups: Group A: 30% ethenolic extract of Indian propolis, Group B: Recaldent(™), Group C: Sterile water. Verbal rating scale was used to record the degree of hypersensitivity based on patient's response to tactile and air blast stimuli. The baseline scores were obtained. Each intervention group received applications of their respective agents consecutively on 1(st), 7(th), 14(th), and 21(st) day. After each application the scores were recorded. RESULTS: Both the 30% Indian propolis and Recaldent(™) showed significant reduction in DH. CONCLUSION: Recaldent(™) was found to be significantly better in reducing the DH compared to propolis and sterile water (P < 0.01).